Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma

被引：8

作者：

Eich, Hans Theodor ^{[1
]}

Mueller, Rolf-Peter ^{[1
]}

机构：

[1] Univ Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany

来源：

STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷 / Suppl 2期

关键词：

Hodgkin's lymphoma; involved field radiotherapy; combined modality treatment; quality assurance;

D O I：

10.1007/s00066-007-2007-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：16 / 18

页数：3

共 16 条

[1]

Bölling T, 2006, STRAHLENTHER ONKOL, V182, P443, DOI 10.1007/s00066-006-1517-9

[2]

Dörr W, 2006, STRAHLENTHER ONKOL, V182, P1, DOI 10.1007/s00066-006-1471-6

[3]

Dühmke E, 2001, J CLIN ONCOL, V19, P2905

[4] Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma -: A comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group [J].

Eich, HT ;

Haverkamp, U ;

Engert, A ;

Kocher, M ;

Skripnitchenko, R ;

Brillant, C ;

Sehlen, S ;

Dühmke, E ;

Diehl, V ;

Müller, RP .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :860-865

[5] Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group [J].

Eich, HT ;

Staar, S ;

Gossmann, A ;

Hansemann, K ;

Skripnitchenko, R ;

Kocher, M ;

Semrau, R ;

Engert, A ;

Josting, A ;

Franklin, J ;

Krug, B ;

Diehl, V ;

Müller, RP .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04) :1121-1127

[6]

EICH HT, 2005, ONKOLOGE, V11, P924

[7] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].

Engert, A ;

Schiller, P ;

Josting, A ;

Herrmann, R ;

Koch, P ;

Sieber, M ;

Boissevain, F ;

de Wit, M ;

Mezger, J ;

Dühmke, E ;

Willich, N ;

Müller, RP ;

Schmidt, BF ;

Renner, H ;

Müller-Hermelink, HK ;

Pfistner, B ;

Wolf, J ;

Hasenclever, D ;

Löffler, M ;

Diehl, V .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608

[8]

Grosu AL, 2005, STRAHLENTHER ONKOL, V181, P483, DOI 10.1007/s00066-005-1422-7

[9]

KAPLAN HS, 1975, CANCER, V36, P796, DOI 10.1002/1097-0142(197508)36:2+<796::AID-CNCR2820360825>3.0.CO

[10]

2-N

← 1 2 →